dr. strosberg discusses results for keynote-158
Published 5 years ago • 115 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:24
dr. strosberg discusses results for keynote-158
-
1:43
dr. strosberg discusses updates from the netter-1 study
-
2:08
dr. strosberg discusses trials in neuroendocrine tumors
-
2:16
dr. strosberg on quality of life for midgut neuroendocrine tumors
-
6:35
dr. michael holinstat presents new preclinical data for cs585 at esc congress 2024
-
1:14
dr. strosberg on radiolabeled somatostatin analogs in gep-nets
-
1:42
keynote-006: results and relevance
-
1:38
dr. strosberg on challenges in the treatment of neuroendocrine tumors
-
4:39
revolutionary bioprocessor by finalspark - human brain organoids
-
11:30
who is a good candidate for prrt (peptide receptor radionuclide therapy) with jonathan strosberg, md
-
39:24
plenary: the fifth paradigm of scientific discovery
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
56:31
winship grand rounds: august 4, 2021 - jonathan strosberg, md
-
5:43
targeted therapies for the treatment of nets
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
5:46
peptide receptor radionuclide therapy for nets
-
5:20
novel therapies emerging for the treatment of nets
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
4:23
overview of somatostatin analogs for nets
-
1:01
dr. garon on the keynote-001 study in nsclc
-
0:57
dr. decker discusses aes associated with radiation in lung cancer
-
5:25
developments in the nets treatment landscape